An FDA advisory panel recommended agency approval of Avalide, a Bristol-Myers Squibb drug, for an additional use in patients who have not been treated for high blood pressure. Avalide already is a blockbuster drug for treating hypertension in patients who did not respond to other treatments.

Full Story:

Related Summaries